BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 10666192)

  • 41. Prognostic role of natural killer cells in pediatric mixed cellularity and nodular sclerosing Hodgkin's disease.
    Ortaç R; Aktaş S; Diniz G; Erbay A; Vergin C
    Anal Quant Cytol Histol; 2002 Oct; 24(5):249-53. PubMed ID: 12408556
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinically-occult mixed cellularity Hodgkin's disease with Charcot-Leyden crystals.
    Carson HJ; Pellettiere EV
    Leuk Lymphoma; 1996 Sep; 23(1-2):153-7. PubMed ID: 9021699
    [TBL] [Abstract][Full Text] [Related]  

  • 43. High prevalence of a 30-base pair deletion in the Epstein-Barr virus (EBV) latent membrane protein 1 gene and of strain type B EBV in Mexican classical Hodgkin's disease and reactive lymphoid tissue.
    Dirnhofer S; Angeles-Angeles A; Ortiz-Hidalgo C; Reyes E; Gredler E; Krugmann J; Fend F; Quintanilla-Martinez L
    Hum Pathol; 1999 Jul; 30(7):781-7. PubMed ID: 10414496
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The pathologic and clinical heterogeneity of lymphocyte-depleted Hodgkin's disease.
    Kant JA; Hubbard SM; Longo DL; Simon RM; DeVita VT; Jaffe ES
    J Clin Oncol; 1986 Mar; 4(3):284-94. PubMed ID: 3754003
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The prognostic relevance of apoptosis-related proteins in classical Hodgkin's lymphomas.
    Vassallo J; Metze K; Traina F; de Souza CA; Lorand-Metze I
    Leuk Lymphoma; 2003 Mar; 44(3):483-8. PubMed ID: 12688319
    [TBL] [Abstract][Full Text] [Related]  

  • 46. CD30 ligand expression in nonmalignant and Hodgkin's disease-involved lymphoid tissues.
    Gruss HJ; Pinto A; Gloghini A; Wehnes E; Wright B; Boiani N; Aldinucci D; Gattei V; Zagonel V; Smith CA; Kadin ME; von Schilling C; Goodwin RG; Herrmann F; Carbone A
    Am J Pathol; 1996 Aug; 149(2):469-81. PubMed ID: 8701986
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Improved survival in patients with limited stage IIIA Hodgkin's disease treated with combined radiation therapy and chemotherapy.
    Marcus KC; Kalish LA; Coleman CN; Shulman LN; Rosenthal DS; Canellos GP; Mauch PM
    J Clin Oncol; 1994 Dec; 12(12):2567-72. PubMed ID: 7989930
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Progression-free survival of early interim PET-positive patients with advanced stage Hodgkin's lymphoma treated with BEACOPP
    Borchmann P; Haverkamp H; Lohri A; Mey U; Kreissl S; Greil R; Markova J; Feuring-Buske M; Meissner J; Dührsen U; Ostermann H; Keller U; Maschmeyer G; Kuhnert G; Dietlein M; Kobe C; Eich H; Baues C; Stein H; Fuchs M; Diehl V; Engert A
    Lancet Oncol; 2017 Apr; 18(4):454-463. PubMed ID: 28236583
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lymphocyte predominant Hodgkin's disease: a clinicopathologic comparative study of histologic and immunophenotypic subtypes.
    Crennan E; D'Costa I; Liew KH; Thompson J; Laidlaw C; Cooper I; Quong G
    Int J Radiat Oncol Biol Phys; 1995 Jan; 31(2):333-7. PubMed ID: 7530700
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hodgkin's disease in Greece: a retrospective clinicopathologic study of 78 cases.
    Floros D; Papakyriazis N; Boutis L; Symeonidis A
    J Surg Oncol; 1982 Jun; 20(2):119-23. PubMed ID: 7078192
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical significance of soluble CD30 antigen in the sera of patients with untreated Hodgkin's disease.
    Gause A; Pohl C; Tschiersch A; Da Costa L; Jung W; Diehl V; Hasenclever D; Pfreundschuh M
    Blood; 1991 May; 77(9):1983-8. PubMed ID: 1850308
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hodgkin's disease of Waldeyer's ring. Clinical and histoimmunophenotypic findings and association with Epstein-Barr virus in 16 cases.
    Kapadia SB; Roman LN; Kingma DW; Jaffe ES; Frizzera G
    Am J Surg Pathol; 1995 Dec; 19(12):1431-9. PubMed ID: 7503365
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Detection of Epstein-Barr virus messenger RNA in Reed-Sternberg cells of Hodgkin's disease by in situ hybridization with biotinylated probes on specially processed modified acetone methyl benzoate xylene (ModAMeX) sections.
    Brousset P; Chittal S; Schlaifer D; Icart J; Payen C; Rigal-Huguet F; Voigt JJ; Delsol G
    Blood; 1991 Apr; 77(8):1781-6. PubMed ID: 1849760
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hodgkin's disease and non-Hodgkin's lymphoma containing Reed-Sternberg-like giant cells in Taiwan. A clinicopathologic analysis of 50 cases.
    Hong RL; Su IJ; Chen YC; Hsieh HC; Wang CH; Liu CH; Shen MC
    Cancer; 1992 Mar; 69(5):1254-8. PubMed ID: 1739924
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Spectrum of Hodgkin's disease in children and adults: impact of combined morphologic and phenotypic approach for exclusion of "look-alikes".
    Siddiqui T; Pervez S
    J Pak Med Assoc; 1999 Sep; 49(9):211-4. PubMed ID: 10646321
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Childhood Hodgkin's disease in the United States: an analysis of histologic subtypes and association with Epstein-Barr virus.
    Andriko JA; Aguilera NS; Nandedkar MA; Abbondanzo SL
    Mod Pathol; 1997 Apr; 10(4):366-71. PubMed ID: 9110300
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CD30 ligand in lymphoma patients with CD30+ tumors.
    Younes A; Consoli U; Snell V; Clodi K; Kliche KO; Palmer JL; Gruss HJ; Armitage R; Thomas EK; Cabanillas F; Andreeff M
    J Clin Oncol; 1997 Nov; 15(11):3355-62. PubMed ID: 9363866
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Increased frequency of HLA-DPB1*0301 in Hodgkin's disease suggests that susceptibility is HVR-sequence and subtype-associated.
    Taylor GM; Gokhale DA; Crowther D; Woll P; Harris M; Alexander F; Jarrett R; Cartwright RA
    Leukemia; 1996 May; 10(5):854-9. PubMed ID: 8656683
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Differential chemokine expression in tissues involved by Hodgkin's disease: direct correlation of eotaxin expression and tissue eosinophilia.
    Teruya-Feldstein J; Jaffe ES; Burd PR; Kingma DW; Setsuda JE; Tosato G
    Blood; 1999 Apr; 93(8):2463-70. PubMed ID: 10194423
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognostic factors for subdiaphragmatic involvement in clinical stage I-II supradiaphragmatic Hodgkin's disease: a retrospective analysis of the GHSG.
    Rueffer U; Sieber M; Josting A; Breuer K; Grotenhermen FJ; Bredenfeld H; Tesch H; Nisters-Backes H; Engert A; Diehl V
    Ann Oncol; 1999 Nov; 10(11):1343-8. PubMed ID: 10631463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.